Interview with Syngene at CPHI in Frankfurt, Germany

Published on: 

KEY LEARNING OBJECTIVES

  • Syngene is an end-to-end CRO/CDMO which offers standalone as well as integrated services for small molecules and biologics
  • We not only have capabilities but also capacity to fulfil commercial manufacturing requirements
  • We can be a innovation partner for niche areas as well as small biotech/pharma companies